Levin Ilan
SEC insider (Form 3/4/5 filer). CIK 0001849189. Director & 10% Owner at Silexion Therapeutics Corp (SLXN). 2 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2025. Located in RAMAT GAN, L3.
Companies Levin Ilan has filed insider reports for
- Silexion Therapeutics Corp (SLXN): Director, 10% Owner
Levin Ilan
CIK: 0001849189
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLXN
Silexion Therapeutics Corp
Director10% Owner